| 401 | ECORelectroCore, Inc. |
$32M |
-43.6% |
2025 |
| 402 | VSTMVerastem, Inc. |
$30.9M |
-677.6% |
2025 |
| 403 | FHTXFoghorn Therapeutics Inc. |
$30.9M |
-240.3% |
2025 |
| 404 | SCLXScilex Holding Co |
$30.3M |
-1,236.4% |
2025 |
| 405 | ICCCImmucell Corp |
$27.6M |
-3.8% |
2025 |
| 406 | SRTSSensus Healthcare, Inc. |
$27.5M |
-28.1% |
2025 |
| 407 | CUECue Biopharma, Inc. |
$27.5M |
-96.9% |
2025 |
| 408 | TRDAEntrada Therapeutics, Inc. |
$25.4M |
-565.5% |
2025 |
| 409 | MGXMetagenomi Therapeutics, Inc. |
$25.2M |
-348.5% |
2025 |
| 410 | HYFTMindWalk Holdings Corp. |
CA$24.5M |
-123.3% |
2025 |
| 411 | ALMSAlumis Inc. |
$24.1M |
-1,011.7% |
2025 |
| 412 | BDMDBaird Medical Investment Holdings Ltd |
$22.5M |
-121.0% |
2025 |
| 413 | NAMSNewAmsterdam Pharma Co N.V. |
$22.5M |
-905.7% |
2025 |
| 414 | DRIODarioHealth Corp. |
$22.4M |
-186.6% |
2025 |
| 415 | ALECAlector, Inc. |
$21M |
-679.2% |
2025 |
| 416 | ZJYLJin Medical International Ltd. |
$20.7M |
5.8% |
2025 |
| 417 | SCYXScynexis Inc |
$20.6M |
-41.8% |
2025 |
| 418 | MDAISpectral AI, Inc. |
$19.7M |
-38.5% |
2025 |
| 419 | SLGLSol-Gel Technologies Ltd. |
$19.4M |
-31.6% |
2025 |
| 420 | POCIPrecision Optics Corporation, Inc. |
$19.1M |
-30.3% |
2025 |
| 421 | LENZLENZ Therapeutics, Inc. |
$19.1M |
-430.3% |
2025 |
| 422 | NEPHNephros Inc |
$18.8M |
6.4% |
2025 |
| 423 | OABIOmniAb, Inc. |
$18.7M |
-347.0% |
2025 |
| 424 | MDWDMediWound Ltd. |
$17M |
-140.8% |
2025 |
| 425 | PTHSPelthos Therapeutics Inc. |
$16.8M |
-257.9% |
2025 |
| 426 | ZYBTZhengye Biotechnology Holding Ltd |
$16.6M |
-60.0% |
2025 |
| 427 | QUREuniQure N.V. |
$16.1M |
-1,236.0% |
2025 |
| 428 | PROFProfound Medical Corp. |
$16.1M |
-264.4% |
2025 |
| 429 | PRQRProQR Therapeutics N.V. |
€15.9M |
-265.2% |
2025 |
| 430 | RLAYRelay Therapeutics, Inc. |
$15.4M |
-1,800.6% |
2025 |
| 431 | LCTXLineage Cell Therapeutics, Inc. |
$14.6M |
-436.5% |
2025 |
| 432 | IRDOpus Genetics, Inc. |
$14.2M |
-349.3% |
2025 |
| 433 | ABUSArbutus Biopharma Corp |
$14.1M |
-237.9% |
2025 |
| 434 | PYXSPyxis Oncology, Inc. |
$13.9M |
-574.5% |
2025 |
| 435 | HYPRHyperfine, Inc. |
$13.6M |
-262.3% |
2025 |
| 436 | CVCapsoVision, Inc |
$13.6M |
-186.8% |
2025 |
| 437 | TNXPTonix Pharmaceuticals Holding Corp. |
$13.1M |
-946.2% |
2025 |
| 438 | NNOXNano-X Imaging Ltd. |
$13M |
-576.1% |
2025 |
| 439 | EVMNEvommune, Inc. |
$13M |
-529.8% |
2025 |
| 440 | ELUTElutia Inc. |
$12.3M |
434.2% |
2025 |
| 441 | PRLDPrelude Therapeutics Inc |
$12.1M |
-819.6% |
2025 |
| 442 | CRBUCaribou Biosciences, Inc. |
$11.2M |
-1,327.4% |
2025 |
| 443 | CBIOCrescent Biopharma, Inc. |
$10.8M |
-1,419.6% |
2025 |
| 444 | TCRXTScan Therapeutics, Inc. |
$10.3M |
-1,256.8% |
2025 |
| 445 | ACOGAlpha Cognition Inc. |
$10.2M |
-202.2% |
2025 |
| 446 | ZBIOZenas BioPharma, Inc. |
$10M |
-3,777.4% |
2025 |
| 447 | JANXJanux Therapeutics, Inc. |
$10M |
-1,136.3% |
2025 |
| 448 | TSHATaysha Gene Therapies, Inc. |
$9.8M |
-1,115.3% |
2025 |
| 449 | PGENPrecigen, Inc. |
$9.7M |
-2,588.2% |
2025 |
| 450 | PRTAProthena Corp Public Ltd Co |
$9.7M |
-2,520.6% |
2025 |